Anne Le Bouter

Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data

Petra van der Groep, Anne Le Bouter, Rianne van der Zanden et al. · Journal of Clinical Pathology · 2006 · 100 citations · Full text

Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT

Rabah Redjoul, Anne Le Bouter, Vincent Parinet et al. · The Lancet Haematology · 2021 · 77 citations · Full text

Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus saprophyticus clinical isolates

Anne Le Bouter, Roland Leclercq, Vincent Cattoir · International Journal of Antimicrobial Agents · 2010 · 35 citations · Full text

Antimicrobial Resistance Gene, Antimicrobial Susceptibility, Health Sciences +9

New Strategy for Rapid Diagnosis and Characterization of Keratomycosis

P. Goldschmidt, Sandrine Degorge, Oudy Semoun et al. · Ophthalmology · 2012 · 16 citations

Histopathology, Diagnosis, Pathology +4

Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral “variants of concern”: Implications for clinical use

Slim Fourati, Alexandre Soulier, Aurélie Gourgeon et al. · Journal of Clinical Virology · 2021 · 16 citations · Full text

Sars-cov-2 Antigen, Diagnostic Virology, Clinical Use +7